Literature DB >> 2845063

Effects of adrenalectomy and glucocorticoids on the peptides CRF-41, AVP and oxytocin in rat hypophysial portal blood.

G Fink1, I C Robinson, L A Tannahill.   

Abstract

1. The effects of adrenalectomy (3 weeks) and dexamethasone (3 h) treatment on the release of corticotrophin-releasing factor-41 (CRF-41), arginine vasopressin (AVP), oxytocin (OT), adrenocorticotrophin (ACTH) and corticosterone were studied in adult female Wistar rats. 2. The animals were anaesthetized with sodium pentobarbitone which, as assessed by the effects on the circadian rhythm of plasma ACTH and corticosterone, appeared to be a better anaesthetic than either urethane or alphaxalone for studies on the hypothalamic-pituitary-adrenal system. 3. Adrenalectomy increased the concentrations of ACTH in peripheral plasma and the output of CRF-41 and AVP into hypophysial portal plasma. 4. Dexamethasone administered to adrenalectomized rats significantly reduced the concentration of ACTH in peripheral plasma and the amount of AVP released into portal plasma. However, dexamethasone did not affect the output of CRF-41 into portal blood. 5. The output of OT into portal plasma was unaffected by either adrenalectomy or dexamethasone treatment. 6. Dexamethasone administered to adrenalectomized rats reduced significantly the ACTH response to CRF-41. 7. These results show that the feed-back action of glucocorticoids is mediated by two mechanisms. The increased release of ACTH which follows adrenolectomy [corrected] is produced predominantly by an increased release of both CRF-41 and AVP into hypophysial portal blood. The intermediate negative feed-back of glucocorticoids is produced by a reduction in the output of AVP but not CRF-41 into portal blood and, as well, by a significant reduction in the responsiveness of the anterior pituitary gland to CRF-41.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2845063      PMCID: PMC1191852          DOI: 10.1113/jphysiol.1988.sp017165

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  44 in total

1.  The paraventriculo-infundibular corticotropin releasing factor (CRF) pathway as revealed by immunocytochemistry in long-term hypophysectomized or adrenalectomized rats.

Authors:  I Merchenthaler; S Vigh; P Petrusz; A V Schally
Journal:  Regul Pept       Date:  1983-03

Review 2.  Physiological functions of glucocorticoids in stress and their relation to pharmacological actions.

Authors:  A Munck; P M Guyre; N J Holbrook
Journal:  Endocr Rev       Date:  1984       Impact factor: 19.871

3.  Effects of synthetic ovine corticotropin-releasing factor, glucocorticoids, catecholamines, neurohypophysial peptides, and other substances on cultured corticotropic cells.

Authors:  W Vale; J Vaughan; M Smith; G Yamamoto; J Rivier; C Rivier
Journal:  Endocrinology       Date:  1983-09       Impact factor: 4.736

4.  Thyrotropin-releasing hormone in rat pituitary stalk blood and hypothalamus: studies with high performance liquid chromatography.

Authors:  W J Sheward; A J Harmar; H M Fraser; G Fink
Journal:  Endocrinology       Date:  1983-11       Impact factor: 4.736

5.  Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin.

Authors:  G E Gillies; E A Linton; P J Lowry
Journal:  Nature       Date:  1982-09-23       Impact factor: 49.962

6.  Glucocorticoid regulation of pro-opiomelanocortin gene transcription in the rat pituitary.

Authors:  J H Eberwine; J L Roberts
Journal:  J Biol Chem       Date:  1984-02-25       Impact factor: 5.157

7.  Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study.

Authors:  L W Swanson; P E Sawchenko; J Rivier; W W Vale
Journal:  Neuroendocrinology       Date:  1983       Impact factor: 4.914

8.  Hemorrhage-induced secretion of corticotropin-releasing factor-like immunoreactivity into the rat hypophysial portal circulation and its inhibition by glucocorticoids.

Authors:  P M Plotsky; W Vale
Journal:  Endocrinology       Date:  1984-01       Impact factor: 4.736

9.  Glucocorticoids regulate proopiomelanocortin gene expression in vivo at the levels of transcription and secretion.

Authors:  N C Birnberg; J C Lissitzky; M Hinman; E Herbert
Journal:  Proc Natl Acad Sci U S A       Date:  1983-11       Impact factor: 11.205

10.  Effects of bilateral adrenalectomy on immunoreactive corticotropin-releasing factor in the rat median eminence and intermediate-posterior pituitary.

Authors:  T Suda; N Tomori; F Tozawa; T Mouri; H Demura; K Shizume
Journal:  Endocrinology       Date:  1983-09       Impact factor: 4.736

View more
  21 in total

1.  Variations in the response of pituitary lactotrophs to oxytocin during the rat estrous cycle.

Authors:  Joël Tabak; Arturo E Gonzalez-Iglesias; Natalia Toporikova; Richard Bertram; Marc E Freeman
Journal:  Endocrinology       Date:  2010-02-22       Impact factor: 4.736

2.  Pituitary portal plasma levels of oxytocin during the estrous cycle, lactation, and hyperprolactinemia.

Authors:  D K Sarkar; S A Frautschy; N Mitsugi
Journal:  Ann N Y Acad Sci       Date:  1992-06-12       Impact factor: 5.691

3.  Quantifying nonlinear interactions within the hypothalamo-pituitary-adrenal axis in the conscious horse.

Authors:  Daniel M Keenan; Sue Alexander; Clifford Irvine; Johannes D Veldhuis
Journal:  Endocrinology       Date:  2008-11-20       Impact factor: 4.736

4.  Spontaneous and CRH-Induced Excitability and Calcium Signaling in Mice Corticotrophs Involves Sodium, Calcium, and Cation-Conducting Channels.

Authors:  Hana Zemkova; Melanija Tomić; Marek Kucka; Greti Aguilera; Stanko S Stojilkovic
Journal:  Endocrinology       Date:  2016-02-22       Impact factor: 4.736

5.  Influence of steroids on the hypothalamic corticotropin-releasing factor and preproenkephalin mRNA responses to stress.

Authors:  S L Lightman; W S Young
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

6.  Corticotropin-releasing factor and glucocorticoid receptor (GR) gene expression in the paraventricular nucleus of immune-challenged transgenic mice expressing type II GR antisense ribonucleic acid.

Authors:  N Laflamme; N Barden; S Rivest
Journal:  J Mol Neurosci       Date:  1997-06       Impact factor: 3.444

7.  Regulation of Pulsatile and Entropic ACTH Secretion Under Fixed Exogenous Secretagogue Clamps.

Authors:  Ferdinand Roelfsema; Paul Aoun; Paul Y Takahashi; Dana Erickson; Rebecca Yang; Johannes D Veldhuis
Journal:  J Clin Endocrinol Metab       Date:  2017-07-01       Impact factor: 5.958

Review 8.  Functional implications of brain corticosteroid receptor diversity.

Authors:  E R de Kloet; M S Oitzl; M Joëls
Journal:  Cell Mol Neurobiol       Date:  1993-08       Impact factor: 5.046

Review 9.  Molecular biology of the regulation of hypothalamic hormones.

Authors:  J M Rondeel; I M Jackson
Journal:  J Endocrinol Invest       Date:  1993-03       Impact factor: 4.256

10.  Stress-induced activation of neuronal activity and corticotropin-releasing factor gene expression in the paraventricular nucleus is modulated by glucocorticoids in rats.

Authors:  T Imaki; W Xiao-Quan; T Shibasaki; K Yamada; S Harada; N Chikada; M Naruse; H Demura
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.